1. Home
  2. blog

Sequential bilateral TMS yields ~70% response in adolescents and young adults with treatment‑resistant depression

A peer‑reviewed study in Transcranial Magnetic Stimulation reported ~70% response and 42% remission in 33 adolescents and young adults with treatment‑resistant depression using a sequential bilateral TMS protocol that adds a short right‑side iTBS sequence to standard 10 Hz left stimulation.

30 Jun 2026

Meta unveils Brain2Qwerty v2: MEG-based brain‑to‑text hits 61% word accuracy on early data

Meta announced Brain2Qwerty v2, a MEG‑based non‑invasive brain‑to‑text system that achieved 61% average word accuracy on data from nine volunteers and plans to release training code and a dataset as part of its Digital Brain Project.

30 Jun 2026

How brain–computer interface chips work and where they are used

A concise explainer of brain–computer interface chips: what they are, how they read neural signals, common implant options and clinical uses for mobility and communication, and the main technical and ethical issues.

30 Jun 2026

Paper shows Soto–Alexandrov vestibular neuron model reduces to second-order near Hopf point

A Moscow University Mechanics Bulletin paper demonstrates that the Soto–Alexandrov third‑order model of vestibular afferent neurons can be reduced to a second‑order system near an Andronov–Hopf bifurcation by approximating the potassium inactivation variable hK as constant (≈0.875). The reduction preserves the model’s limit‑cycle projection and simplifies analysis of bistability and state transitions.

29 Jun 2026

Eight weeks of device-guided slow breathing reduces sympathetic nerve spikes in veterans with PTSD

A randomized, double-blind trial of 25 veterans with PTSD found that eight weeks of daily device-guided slow breathing reduced muscle sympathetic nerve responses to an acute mental-stress task, though resting blood pressure and heart rate were unchanged.

29 Jun 2026

VR plus nerve stimulation improves arm and hand recovery after stroke

A 2026 randomized feasibility trial in Nature Medicine found that MultiSensy — immersive VR synchronized with transcutaneous electrical nerve stimulation — produced larger improvements in upper-limb motor scores, functional use, and touch perception than conventional rehab in 34 patients more than three months after stroke.

29 Jun 2026

Common constipation drug improved memory and attention in people with remitted depression

A randomized trial of 50 adults in remission from depression found that one week of 2 mg daily prucalopride improved memory, attention and processing speed versus placebo, with no significant short-term side effects. The study appears in Psychological Medicine (15 June 2026, DOI linked).

27 Jun 2026

Vagus nerve implicated in α‑synuclein spread in Parkinson’s and in cholinergic/inflammatory pathways in Alzheimer’s

Recent experimental and neuropathology studies reinforce the vagus nerve’s role in Parkinson’s—where gut‑origin α‑synuclein can travel to the brainstem—and implicate vagal pathways in Alzheimer’s via cholinergic and inflammatory networks. Early clinical trials and a 2025 meta‑analysis show promising but inconsistent effects for noninvasive VNS.

27 Jun 2026

Theta‑band frontoparietal tACS reduced cue‑related striatal and amygdala activity in randomized OUD fMRI trial

A pre-registered, triple‑blind randomized tACS‑fMRI trial (NCT03907644) found a single 20‑minute, in‑phase 6 Hz HD‑tACS session reduced drug‑cue BOLD responses in striatum and amygdala but produced no group difference in self‑reported craving in 60 men with opioid use disorder.

27 Jun 2026

Epilepsy Foundation awards $250,000 at 2026 Shark Tank; NeuroWeaves wins $200,000 for long‑wear EEG

At the Epilepsy Foundation's 2026 Shark Tank Competition on June 18, NeuroWeaves won a $200,000 Investment Prize for gold‑thread EEG electrodes; the Foundation awarded $250,000 total, with a Community Award to a CDKL5 repurposing project.

27 Jun 2026

Next wave of BCI firms builds on pioneers to tackle technical and clinical gaps

Ability Neurotech and other emerging BCI firms are adopting 'fast follower' strategies, focusing on alternative electrode materials, nanoparticles and more complete system designs to address technical and clinical limitations identified by pioneers such as Neuralink.

26 Jun 2026

Hippocampal ripples encode predicted uncertainty and shape cortical responses, intracranial study shows

Intracranial recordings from 17 patients show hippocampal sharp‑wave ripples increase before unpredictable stimuli (high entropy) and are linked to faster responses; poststimulus fusiform→hippocampus gamma carries surprise‑related signals.

26 Jun 2026

Coherence Neuro begins first-in-human trial of Cipher BCI

Coherence Neuro has launched a first-in-human trial of its Cipher brain-computer interface, led by Dr. Andrew Morokoff, to test intraoperative mapping and stimulation during brain tumor surgery. Results will guide development of SOMA-1, a planned wireless implantable therapeutic BCI.

26 Jun 2026

Scientific Reports study: menstrual cycle alters cardiac autonomic control but not strength or mood

A Scientific Reports study found menstrual-cycle phases change heart rate variability and autonomic balance but did not alter muscle strength, mood or motivation; the result suggests wearables' HRV readings can reflect predictable hormonal shifts.

26 Jun 2026

Injectable 'SEED' implant delivers targeted peripheral nerve stimulation

NYU Abu Dhabi researchers published a Science Advances paper on SEED, a seed‑sized injectable peripheral nerve stimulator powered wirelessly; the device has shown consistent control in rats but remains at least 5–10 years from clinical use.

26 Jun 2026

Lleida pilot study: treadmill, VR and tDCS together improved balance and dual-task gait in Parkinson's

A 23-patient pilot study from the University of Lleida and IRBLleida found that combining treadmill training, virtual reality and tDCS improved balance and increased gait cadence during dual-motor tasks in people with Parkinson's. The data are preliminary and published in Neurological Sciences.

24 Jun 2026

Harvard senior builds microfabricated ultrasonic cuff to steer vagus nerve stimulation

A Harvard senior built a microfabricated PMUT-based ultrasonic cuff designed to beam-steer and selectively stimulate the vagus nerve; the capstone project began microfabrication in May 2025 and remains a prototype without reported testing.

24 Jun 2026

San Antonio woman is first in Texas to receive FDA‑approved SetPoint implant for rheumatoid arthritis

Susan Perry became the first person in Texas to receive the FDA‑approved SetPoint vagus‑nerve implant for rheumatoid arthritis in February, reporting reduced pain and lower inflammation; a randomized trial published earlier this year showed sustained one‑year benefits for people with the device.

24 Jun 2026

New London clinic Naya Health offers TMS for chronic pain, burnout and anxiety

Naya Health has opened a London clinic offering Transcranial Magnetic Stimulation (TMS) for conditions including chronic pain, anxiety and burnout, and will use a proprietary NayaScore to track brain-function changes. Sessions start from £350, the company says.

24 Jun 2026

Aligned heart rates signal real-world social connection and engagement

A study finds that heart-rate alignment between people correlates with physical and emotional closeness and may track social engagement in real-world interactions. Researchers say wearable sensors could measure this signal but caution that more validation and privacy safeguards are needed.

24 Jun 2026

Amazon launches Sleep Studio on Echo speakers to help children's bedtime routines

Amazon launched Sleep Studio on Echo smart speakers, bundling stories, sounds and guided meditations from Headspace, Moshi and Calm and adding scheduling and light controls via the Amazon Kids dashboard. Sleep Studio is available only with an Amazon Kids Plus subscription ($6/month).

22 Jun 2026

Rewiring the Brain: Exomind therapy pitched as 30‑minute, drug‑free TMS for mood and brain fog

Exomind therapy is being promoted as a 30‑minute, drug‑free TMS option for depression, anxiety, menopause‑related brain fog and drug‑linked cravings. The promotional claims did not include peer‑reviewed trial data or regulatory details.

22 Jun 2026

Waveform switching salvages 77.9% of failed spinal cord stimulation trials, systematic review reports

A 2026 systematic review in Neuromodulation found waveform switching restored analgesia in 77.9% of salvage trials across 1,591 patients with failed spinal cord stimulation, but many interventions involved hardware changes and long-term durability is unclear.

22 Jun 2026

How personal loss led Ria Rustagi to build Neuphony and launch a CDSCO‑approved headset

Neuphony CEO Ria Rustagi launched Sychedelic, a CDSCO‑approved headphone pairing PPG sensors with tDCS and adaptive music; the device is on Kickstarter after a $3.5M seed round. Neuphony also sells EEG headbands, a Flex Cap for researchers and a developer kit.

22 Jun 2026

BrainPatch AI CEO Nickolai Vysokov Joins StartX Accelerator at Stanford University

Dr Nickolai Vysokov, CEO and Co-Founder of BrainPatch AI, will spend the summer at the StartX Accelerator at Stanford University, strengthening the company’s presence in Silicon Valley and engaging with the venture capital ecosystem ahead of BrainPatch AI’s upcoming Seed Round.

1 Jun 2026

Search

About Us

Stay updated with the latest events and innovations from BrainPatch.ai by following our news and updates!

Categories

Archives